ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
30.27 USD
-0.04 (-0.13%)
30.5 USD
+0.23 (+0.76%)
Taking everything into account, ENOV scores 4 out of 10 in our fundamental rating. ENOV was compared to 188 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ENOV while its profitability can be described as average. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year ENOV was profitable.
In the past year ENOV had a positive cash flow from operations.
In multiple years ENOV reported negative net income over the last 5 years.
ENOV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ENOV's Return On Assets of -30.84% is in line compared to the rest of the industry. ENOV outperforms 43.09% of its industry peers.
ENOV's Return On Equity of -67.66% is in line compared to the rest of the industry. ENOV outperforms 45.21% of its industry peers.
ENOV has a Return On Invested Capital of 0.12%. This is in the better half of the industry: ENOV outperforms 65.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ENOV's Operating Margin of 0.25% is fine compared to the rest of the industry. ENOV outperforms 65.43% of its industry peers.
ENOV's Operating Margin has declined in the last couple of years.
ENOV has a Gross Margin (57.19%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ENOV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENOV is destroying value.
ENOV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ENOV has more shares outstanding
ENOV has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.83, we must say that ENOV is in the distress zone and has some risk of bankruptcy.
ENOV has a Altman-Z score (0.83) which is comparable to the rest of the industry.
The Debt to FCF ratio of ENOV is 59.72, which is on the high side as it means it would take ENOV, 59.72 years of fcf income to pay off all of its debts.
ENOV's Debt to FCF ratio of 59.72 is fine compared to the rest of the industry. ENOV outperforms 67.02% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
The Debt to Equity ratio of ENOV (0.66) is worse than 64.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.83 |
ROIC/WACC0.02
WACC7.26%
2.3 Liquidity
A Current Ratio of 2.22 indicates that ENOV has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.22, ENOV is doing worse than 60.64% of the companies in the same industry.
A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
The Quick ratio of ENOV (1.16) is worse than 70.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.14% over the past year.
Measured over the past years, ENOV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.18% on average per year.
Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 11.57% in the last year.
ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
ENOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
Based on estimates for the next years, ENOV will show a quite strong growth in Revenue. The Revenue will grow by 8.87% on average per year.
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.09, which indicates a very decent valuation of ENOV.
Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 94.68% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. ENOV is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 8.47, the valuation of ENOV can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 96.28% of the companies in the same industry.
ENOV is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.09 | ||
| Fwd PE | 8.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaply inside the industry as 90.43% of the companies are valued more expensively.
70.74% of the companies in the same industry are more expensive than ENOV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.04 | ||
| EV/EBITDA | 10.28 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ENOV's earnings are expected to grow with 13.12% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y12.38%
EPS Next 3Y13.12%
5. Dividend
5.1 Amount
ENOV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.27
-0.04 (-0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.31%
Inst Owner Change-2.39%
Ins Owners1.19%
Ins Owner Change0.8%
Market Cap1.73B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target51 (68.48%)
Short Float %13.73%
Short Ratio9.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-7.98%
PT rev (3m)-7.98%
EPS NQ rev (1m)-5.34%
EPS NQ rev (3m)-5.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-1.26%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.09 | ||
| Fwd PE | 8.47 | ||
| P/S | 0.78 | ||
| P/FCF | 76.04 | ||
| P/OCF | 7.97 | ||
| P/B | 0.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.28 |
EPS(TTM)3.33
EY11%
EPS(NY)3.57
Fwd EY11.81%
FCF(TTM)0.4
FCFY1.32%
OCF(TTM)3.8
OCFY12.54%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.72
PEG (5Y)N/A
Graham Number51.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.83 |
F-Score4
WACC7.26%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year74.87%
EBIT Next 3Y29.81%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 12.58% in the next year.